GH/IGF-1 axis modulation Several Sikiric studies (2010-2020) reported indirect modulation of the GH-IGF-1 axis by BPC-157, with moderate induction of GH receptor expression in scar tissue
The study focused on patients with platinum-resistant ovarian cancer whose tumors had high levels of folate receptor alpha
1419, PL 14736) and wound healing, stable in human gastric juice and has no reported toxicity[1]
Common administration methods include: Subcutaneous injections (most common, high bioavailability) Oral capsules (for peptides stable in digestion) Nasal sprays (for neuro-targeted peptides) Topical creams (for skin and soft tissue concerns) Treatment is often personalized , with protocols tailored to individual goals (e.g., muscle growth, anti-aging, healing), and monitored via lab tests to ensure optimal dosing and outcomes
How to Learn More and Order If you're curious to explore this peptide further or ready to try it yourself, visit the official Healthletic product page below
Yes, but not simultaneously